Clinical Trial Update: Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nivolumab plus metformin for stage III-IV non-small cell lung cancer unsuitable for surgery; status unknown with results posted in 2020…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• METFORMIN HYDROCHLORIDE (Metformin hydrochloride)
• nivolumab (nivolumab)

Snippet

Sponsor: Northwestern University | Conditions: Recurrent Non-Small Cell Lung Carcinoma, Stage III Non-Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN | Results posted: 2020-10-14